Market Overview 2022-2027:
The global asthma therapeutics market size reached US$
17.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$
20.1 Billion by 2027, exhibiting a growth rate (CAGR) of
2.13% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Asthma Therapeutics Market Trends:
The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global asthma therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, product type, treatment type and route of administration.
Breakup by Drug Class:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Anti-Inflammatory Drugs
- Bronchodilators
- Combination Therapies
Breakup by Product Type:
- Inhalers
- Dry Powder Inhalers
- Metered Dose Inhalers
- Soft Mist Inhalers
- Nebulizers
- Pneumatic Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
Breakup by Treatment Type:
- Quick-Relief Medications
- Long-Term Asthma Control Medications
Breakup by Route of Administration:
- Inhalation
- Oral
- Parenteral
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Drug Class, Product Type, Treatment Type, Route of Administration, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Asthma Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Anti-Inflammatory Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Bronchodilators
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Combination Therapies
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product Type
7.1 Inhalers
7.1.1 Market Trends
7.1.2 Major Types
7.1.2.1 Dry Powder Inhalers
7.1.2.2 Metered Dose Inhalers
7.1.2.3 Soft Mist Inhalers
7.1.3 Market Forecast
7.2 Nebulizers
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Pneumatic Nebulizers
7.2.2.2 Ultrasonic Nebulizers
7.2.2.3 Mesh Nebulizers
7.2.3 Market Forecast
8 Market Breakup by Treatment Type
8.1 Quick-Relief Medications
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Long-Term Asthma Control Medications
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Inhalation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Parenteral
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AstraZeneca PLC
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Abbott Laboratories
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Amgen Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biogen Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Boehringer Ingelheim International GmbH
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 F. Hoffmann-La Roche Ltd.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 GlaxoSmithKline Plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Merck Sharp & Dohme Corp.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Novartis International AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sunovion Pharmaceuticals Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 SWOT Analysis
15.3.11 Teva Pharmaceutical Industries Ltd.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2021
Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2021
Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2021
Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2021
Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Asthma Therapeutics (Combination Therapies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Asthma Therapeutics (Combination Therapies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Asthma Therapeutics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Asthma Therapeutics Market Structure
Table 8: Global: Asthma Therapeutics Market: Key Players